Cargando…

The impact of repeated freeze‐thaw cycles on antiphospholipid antibody titer

ESSENTIALS: Limited data are available of freeze‐thaw effect on anticardiolipin and anti‐beta2‐glycoprotein I antibodies. Patient samples with antibody titer over a broad range were analyzed in a standardized freezing‐thawing scheme. aCL and aβ2GPI IgG and IgM titers are stable over time and after r...

Descripción completa

Detalles Bibliográficos
Autores principales: Maelegheer, Karel, Devreese, Katrien M. J.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2018
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6055575/
https://www.ncbi.nlm.nih.gov/pubmed/30046740
http://dx.doi.org/10.1002/rth2.12071
_version_ 1783341199414788096
author Maelegheer, Karel
Devreese, Katrien M. J.
author_facet Maelegheer, Karel
Devreese, Katrien M. J.
author_sort Maelegheer, Karel
collection PubMed
description ESSENTIALS: Limited data are available of freeze‐thaw effect on anticardiolipin and anti‐beta2‐glycoprotein I antibodies. Patient samples with antibody titer over a broad range were analyzed in a standardized freezing‐thawing scheme. aCL and aβ2GPI IgG and IgM titers are stable over time and after repeated freeze‐thawing. Repeated use of samples facilitates routine work‐out and use of samples for scientific purposes. BACKGROUND: Pre‐analytical factors, like freeze‐thaw cycles (FTC), can potentially affect results and clinical interpretation. According to the SSC‐ISTH recommendations for antiphospholipid antibodies (aPL) testing, additional FTC should be avoided to maintain the best performance. Patient samples are often analyzed in batch and having one frozen sample aliquot for all aPL tests, that may hamper daily routine work‐out. To use them for study or method validation purpose, sample storage in bio banks is often done in one aliquot also triggering the need for several FTC to be able to use them in different scientific projects. Taking into account the limited scientific literature, the strict guidelines and the potential benefits of repeated FTC we evaluated this pre‐analytical factor. OBJECTIVES: Evaluating the effect of repeated FTC on anticardiolipin (aCL) IgM/IgG and anti‐beta‐2 glycoprotein 1 (aβ2GPI) IgM/IgG antibody titer. PATIENT/METHODS: 42 patient plasmas that were not thawed before, were retrieved from the routine archive (−80°C). All aliquots were analyzed on five consecutive days with an additional, standardized FTC every day. Mann‐Withney tests for statistical differences and a concordance correlation coefficient (CCC) were calculated between the first and following FTC. RESULTS AND CONCLUSION: For all four aPL no statistical difference or degradation from positive to negative was seen, even after five FTC. The CCC between the first and fifth FTC were between 0.98 and 1 for all four aPL. aCL IgM/IgG and aβ2GPI IgM/IgG antibody titer, over a broad titer range, are stable over time and after repeated FTC.
format Online
Article
Text
id pubmed-6055575
institution National Center for Biotechnology Information
language English
publishDate 2018
publisher John Wiley and Sons Inc.
record_format MEDLINE/PubMed
spelling pubmed-60555752018-07-25 The impact of repeated freeze‐thaw cycles on antiphospholipid antibody titer Maelegheer, Karel Devreese, Katrien M. J. Res Pract Thromb Haemost Original Articles: Thrombosis ESSENTIALS: Limited data are available of freeze‐thaw effect on anticardiolipin and anti‐beta2‐glycoprotein I antibodies. Patient samples with antibody titer over a broad range were analyzed in a standardized freezing‐thawing scheme. aCL and aβ2GPI IgG and IgM titers are stable over time and after repeated freeze‐thawing. Repeated use of samples facilitates routine work‐out and use of samples for scientific purposes. BACKGROUND: Pre‐analytical factors, like freeze‐thaw cycles (FTC), can potentially affect results and clinical interpretation. According to the SSC‐ISTH recommendations for antiphospholipid antibodies (aPL) testing, additional FTC should be avoided to maintain the best performance. Patient samples are often analyzed in batch and having one frozen sample aliquot for all aPL tests, that may hamper daily routine work‐out. To use them for study or method validation purpose, sample storage in bio banks is often done in one aliquot also triggering the need for several FTC to be able to use them in different scientific projects. Taking into account the limited scientific literature, the strict guidelines and the potential benefits of repeated FTC we evaluated this pre‐analytical factor. OBJECTIVES: Evaluating the effect of repeated FTC on anticardiolipin (aCL) IgM/IgG and anti‐beta‐2 glycoprotein 1 (aβ2GPI) IgM/IgG antibody titer. PATIENT/METHODS: 42 patient plasmas that were not thawed before, were retrieved from the routine archive (−80°C). All aliquots were analyzed on five consecutive days with an additional, standardized FTC every day. Mann‐Withney tests for statistical differences and a concordance correlation coefficient (CCC) were calculated between the first and following FTC. RESULTS AND CONCLUSION: For all four aPL no statistical difference or degradation from positive to negative was seen, even after five FTC. The CCC between the first and fifth FTC were between 0.98 and 1 for all four aPL. aCL IgM/IgG and aβ2GPI IgM/IgG antibody titer, over a broad titer range, are stable over time and after repeated FTC. John Wiley and Sons Inc. 2018-01-24 /pmc/articles/PMC6055575/ /pubmed/30046740 http://dx.doi.org/10.1002/rth2.12071 Text en © 2018 The Authors. Research and Practice in Thrombosis and Haemostasis published by Wiley Periodicals, Inc on behalf of International Society on Thrombosis and Haemostasis. This is an open access article under the terms of the http://creativecommons.org/licenses/by-nc-nd/4.0/ License, which permits use and distribution in any medium, provided the original work is properly cited, the use is non‐commercial and no modifications or adaptations are made.
spellingShingle Original Articles: Thrombosis
Maelegheer, Karel
Devreese, Katrien M. J.
The impact of repeated freeze‐thaw cycles on antiphospholipid antibody titer
title The impact of repeated freeze‐thaw cycles on antiphospholipid antibody titer
title_full The impact of repeated freeze‐thaw cycles on antiphospholipid antibody titer
title_fullStr The impact of repeated freeze‐thaw cycles on antiphospholipid antibody titer
title_full_unstemmed The impact of repeated freeze‐thaw cycles on antiphospholipid antibody titer
title_short The impact of repeated freeze‐thaw cycles on antiphospholipid antibody titer
title_sort impact of repeated freeze‐thaw cycles on antiphospholipid antibody titer
topic Original Articles: Thrombosis
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6055575/
https://www.ncbi.nlm.nih.gov/pubmed/30046740
http://dx.doi.org/10.1002/rth2.12071
work_keys_str_mv AT maelegheerkarel theimpactofrepeatedfreezethawcyclesonantiphospholipidantibodytiter
AT devreesekatrienmj theimpactofrepeatedfreezethawcyclesonantiphospholipidantibodytiter
AT maelegheerkarel impactofrepeatedfreezethawcyclesonantiphospholipidantibodytiter
AT devreesekatrienmj impactofrepeatedfreezethawcyclesonantiphospholipidantibodytiter